The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Sagility India IPO
Sagility India
MainboardListed

Sagility India IPO

Bidding 5-7 Nov 2024, price band ₹28–30, lot 500 shares.

OverviewAllotment

IPO timeline

  1. Issue open date
    5 Nov 2024
  2. Issue close date
    7 Nov 2024
  3. UPI mandate deadline
    7 Nov 2024
  4. Allotment finalization
    8 Nov 2024
  5. Refund initiation
    8 Nov 2024
  6. Share credit
    11 Nov 2024
  7. Listing date
    12 Nov 2024
  8. Mandate end date
    22 Nov 2024
  9. Lock-in end date for anchor investors (50%)
    8 Dec 2024
  10. Lock-in end date for anchor investors (remaining)
    6 Feb 2025

Sagility India IPO Allotment Status

Allotment date:8 Nov 2024
Registrar:MUFG Intime India Private Limited - Link Intime
  1. Open the registrar's allotment page from the link below.
  2. Select Sagility India from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on MUFG Intime India(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:8 Nov 2024
Shares credited to demat:11 Nov 2024
Listing:12 Nov 2024

Quick Stats

Issue Size:2106cr
Lot Size:500 shares
Min Investment:₹15,000

Price Band

₹28–30
per share

About the Company

Sagility India Limited provides technology-driven business solutions and services to the U.S. healthcare industry, focusing exclusively on healthcare clients, including Payers (health insurers) and Providers (hospitals, physicians, and medical device companies). Their services support Payers with core operations like claims management, enrollment, and clinical functions, as well as Providers with revenue cycle management tasks. They also extend prescription management services to pharmacy benefit managers. Leveraging a global talent pool from delivery centres across India, the Philippines, the U.S., Jamaica, and Colombia, they have been recognised as a leader in the industry by Avasant and Everest. Since their incorporation in 2021 and the acquisition of their predecessor’s healthcare business, they have expanded their client base, serving top U.S. health insurers, and added 22 new clients as of mid-2024.

Strengths

  • Leader in the large, resilient U.S. Payer and Provider solutions market
  • Strong domain expertise in healthcare operations, providing end-to-end service offerings for Payers and Providers
  • Comprehensive suite of scalable, technology-enabled services and solutions, featuring proprietary tools for automation, intelligent intake and content processing, speech processing, interaction analytics, generative AI, and RCM workflow tools
  • Established, long-term relationships with healthcare Payers and Providers that continue to expand
  • Flexible, multi-shore delivery model that is scalable and adheres to certified data protection and service standards
  • Consistently strong financial performance with high margins

Risks

  • The company operates in a highly competitive healthcare services industry, and an inability to compete effectively could negatively impact its business, financial condition, and operational results.
  • Its focus on the U.S. healthcare industry makes it vulnerable to industry-specific factors, such as reduced growth, shifts in outsourcing, and other trends that could adversely affect performance.
  • A significant portion of its assets consists of goodwill and other intangibles; any impairment to these assets may harm its reputation and financial standing.
  • Anti-outsourcing legislation could hinder its ability to serve customers effectively and adversely impact its business, financial condition, and operational outcomes.
  • A potential downgrade in the company’s credit rating may restrict its ability to secure future capital.

Sagility India IPO – Frequently Asked Questions

  • The price band for the Sagility India IPO is set at ₹28 to ₹30 per share.
  • The Sagility India IPO opens on November 5, 2024 and closes on November 7, 2024.
  • The tentative listing date for the Sagility India IPO is November 12, 2024.
  • The Sagility India IPO allotment date is November 8, 2024. Once it is finalised, check your status with your PAN or application number on the website of the registrar, MUFG Intime India Private Limited - Link Intime. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Sagility India IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Sagility India, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Sagility India IPO is 500 shares. Investors must apply for at least one lot (i.e., 500 shares), which costs ₹15,000 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in November 2024